Cytotoxic Effects of Curcumin in Human Retinal Pigment Epithelial Cells

PLoS ONE

Volumn 8, Issue 3, 2013, Pages

  Hollborn, Margrit ^a   Chen, Rui ^a   Wiedemann, Peter ^a   Reichenbach, Andreas ^a   Bringmann, Andreas ^a   Kohen, Leon ^a,b  

^a UNIVERSITY OF LEIPZIG   (Germany)

^b HELIOS Klinikum Aue   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BROXURIDINE; CALPAIN; CASPASE 3; CURCUMIN; FIBROBLAST GROWTH FACTOR 2; MITOGEN ACTIVATED PROTEIN KINASE P38; PROTEIN KINASE B; VASCULOTROPIN;

APOPTOSIS; ARTICLE; CALCIUM CELL LEVEL; CALCIUM SIGNALING; CELL DEATH; CELL FUNCTION; CELL HYPOXIA; CELL PROLIFERATION; CELL VIABILITY; CHEMOTAXIS; CONTROLLED STUDY; CYTOTOXICITY TEST; DNA FRAGMENTATION; DOWN REGULATION; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION; HUMAN; HUMAN CELL; IMMUNOASSAY; IN VITRO STUDY; MITOCHONDRIAL PERMEABILITY; NUCLEOTIDE SEQUENCE; OXIDATIVE STRESS; PIGMENT EPITHELIUM; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN SECRETION; REAL TIME POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

APOPTOSIS REGULATORY PROTEINS; CELL DEATH; CELL PROLIFERATION; CELL SURVIVAL; CHEMOTAXIS; CURCUMIN; CYTOKINES; CYTOTOXINS; DNA FRAGMENTATION; GENE EXPRESSION REGULATION; HUMANS; INTRACELLULAR SPACE; RETINAL PIGMENT EPITHELIUM; SIGNAL TRANSDUCTION;

CURCUMA LONGA;

EID: 84875469358     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0059603     Document Type: Article

References (68)

1. Aggarwal BB, Sung B, (2009) Pharmacological basis for the role of curcumin in chronic diseases: an age-old spice with modern targets. Trends Pharmacol Sci 30: 85-94.
2. Joe B, Vijaykumar M, Lokesh BR, (2004) Biological properties of curcumin-cellular and molecular mechanisms of action. Crit Rev Food Sci Nutr 44: 97-111.
3. Li CJ, Zhan LJ, Dezube BJ, Crumpacker CS, Pardee AB, (1993) Three inhibitors of type 1 human immunodeficiency virus long terminal repeat-directed gene expression and virus replication. Proc Natl Acad Sci U S A 90: 1839-1842.
4. Kim HJ, Yoo HS, Kim JC, Park CS, Choi MS, et al. (2009) Antiviral effect of Curcuma longa Linn extract against hepatitis B virus replication. J Ethnopharmacol 124: 189-196.
5. Kim K, Kim KH, Kim HY, Cho HK, Sakamoto N, et al. (2010) Curcumin inhibits hepatitis C virus replication via suppressing the Akt-SREBP-1 pathway. FEBS Lett 584: 707-712.
6. Rechtman MM, Har-Noy O, Bar-Yishay I, Fishman S, Adamovich Y, et al. (2010) Curcumin inhibits hepatitis B virus via down-regulation of the metabolic coactivator PGC-1α. FEBS Lett 584: 2485-2490.
7. Bharti AC, Panigrahi A, Sharma PK, Gupta N, Kumar R, et al. (2010) Clinical relevance of curcumin-induced immunosuppression in living-related donor renal transplant: an in vitro analysis. Exp Clin Transplant 8: 161-171.
8. Mancuso C, Barone E, (2009) Curcumin in clinical practice: myth or reality? Trends Pharmacol Sci 30: 333-334.
9. Epstein J, Sanderson IR, Macdonald TT, (2010) Curcumin as a therapeutic agent: the evidence from in vitro, animal and human studies. Br J Nutr 103: 1545-1557.
10. Bhaumik S, Anjum R, Rangaraj N, Pardhasaradhi BVV, Khar A, (1999) Curcumin mediated apoptosis in AK-5 tumor cells involves the production of reactive oxygen intermediates. FEBS Lett 456: 311-314.
11. Hadi SM, Asad SF, Singh S, Ahmad A, (2000) Putative mechanism for anticancer and apoptosis-inducing properties of plant-derived polyphenolic compounds. IUBMB Life 50: 167-171.
12. Aggarwal BB, Kumar A, Bharti AC, (2003) Anticancer potential of curcumin: preclinical and clinical studies. Anticancer Res 23: 363-396.
13. Chen J, Da W, Zhang D, Liu Q, Kang J, (2005) Water-soluble antioxidants improve the antioxidant and anticancer activity of low concentrations of curcumin in human leukemia cells. Pharmazie 60: 57-61.
14. Anto RJ, Mukhopadhyay A, Denning K, Aggarwal BB, (2002) Curcumin (diferuloyl-methane) induces apoptosis through activation of caspase-8, BID cleavage and cytochrome c release: its suppression by ectopic expression of Bcl-2 and Bcl-xl. Carcinogenesis 23: 143-150.
15. Aggarwal BB, Shishodia S, Takada Y, Banerjee S, Newman RA, et al. (2005) Curcumin suppresses the paclitaxel-induced nuclear factor-κB pathway in breast cancer cells and inhibits lung metastasis of human breast cancer in nude mice. Clin Cancer Res 11: 7490-7498.
16. Gao X, Deeb D, Jiang H, Liu YB, Dulchavsky SA, et al. (2005) Curcumin differentially sensitizes malignant glioma cells to TRAIL/Apo2L-mediated apoptosis through activation of procaspases and release of cytochrome c from mitochondria. J Exp Ther Oncol 5: 39-48.
17. Marathe S, Negi VD, Chakravortty D, (2009) Curcumin! Spicy panacea for all- friend or foe. Vaccine 28: 291-292.
18. Burgos-Morón E, Calderón-Montaño JM, Salvador J, Robles A, López-Lázaro M, (2010) The dark side of curcumin. Int J Cancer 126: 1771-1775.
19. Beatty S, Koh H, Phil M, Henson D, Boulton M, (2000) The role of oxidative stress in the pathogenesis of age-related macular degeneration. Surv Ophthalmol 45: 115-134.
20. Bailey TA, Kanuga N, Romero IA, Greenwood J, Luthert PJ, et al. (2004) Oxidative stress affects the junctional integrity of retinal pigment epithelial cells. Invest Ophthalmol Vis Sci 45: 675-684.
21. Madsen-Bouterse SA, Kowluru RA, (2008) Oxidative stress and diabetic retinopathy: pathophysiological mechanisms and treatment perspectives. Rev Endocr Metab Disord 9: 315-327.
22. Zheng L, Kern TS, (2009) Role of nitric oxide, superoxide, peroxynitrite and PARP in diabetic retinopathy. Front Biosci 14: 3974-3987.
23. Usui S, Oveson BC, Lee SY, Jo YJ, Yoshida T, et al. (2009) NADPH oxidase plays a central role in cone cell death in retinitis pigmentosa. J Neurochem 110: 1028-1037.
24. Pazdro R, Burgess JR, (2010) The role of vitamin E and oxidative stress in diabetes complications. Mech Ageing Dev 131: 276-286.
25. Mares-Perlman JA, Klein R, Klein BE, Greger JL, Brady WE, (1996) Association of zinc and antioxidant nutrients with age-related maculopathy. Arch Ophthalmol 114: 991-997.
26. Age-Related Eye Disease Study Research Group (2001) A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, ß-carotene, and zinc for age-related macular degeneration and vision loss. AREDS report No. 11. Arch Ophthalmol 119: 1417-1436.
27. Richer S, Stiles W, Statkute L, Pulido J, Frankowski J, et al. (2004) Double-masked, placebo-controlled, randomized trial of lutein and antioxidant supplementation in the intervention of atrophic age-related macular degeneration: the Veterans LAST study (Lutein Antioxidant Supplementation Trial). Optometry 75: 216-230.
28. Kowluru RA, Kanwar M, (2007) Effects of curcumin on retinal oxidative stress and inflammation in diabetes. Nutr Metab 4: 8.
29. Mandal MN, Patlolla JM, Zheng L, Agbaga MP, Tran JT, (2009) Curcumin protects retinal cells from light-and oxidant stress-induced cell death. Free Radic Biol Med 46: 672-679.
30. Vasireddy V, Chavali VR, Joseph VT, Kadam R, Lin JH, et al. (2011) Rescue of photoreceptor degeneration by curcumin in transgenic rats with P23H rhodopsin mutation. PLoS One 6: e21193.
31. Mrudula T, Suryanarayana P, Srinivas PN, Reddy GB, (2007) Effect of curcumin on hyperglycemia-induced vascular endothelial growth factor expression in streptozotocin-induced diabetic rat retina. Biochem Biophys Res Commun 361: 528-532.
32. Gupta SK, Kumar B, Nag TC, Agrawal SS, Agrawal R, et al. (2011) Curcumin prevents experimental diabetic retinopathy in rats through its hypoglycemic, antioxidant, and anti-inflammatory mechanisms. J Ocul Pharmacol Ther 27: 123-130.
33. Burugula B, Ganesh BS, Chintala SK, (2011) Curcumin attenuates staurosporine-mediated death of retinal ganglion cells. Invest Ophthalmol Vis Sci 52: 4263-4273.
34. Wang L, Li C, Guo H, Kern TS, Huang K, et al. (2011) Curcumin inhibits neuronal and vascular degeneration in retina after ischemia and reperfusion injury. PLoS One 6: e23194.
35. Premanand C, Rema M, Sameer MZ, Sujatha M, Balasubramanyam M, (2006) Effect of curcumin on proliferation of human retinal endothelial cells under in vitro conditions. Invest Ophthalmol Vis Sci 47: 2179-2184.
36. Strauss O, (2005) The retinal pigment epithelium in visual function. Physiol Rev 85: 845-881.
37. Roth F, Bindewald A, Holz FG, (2004) Keypathophysiologic pathways in age-related macular disease. Graefes Arch Clin Exp Ophthalmol 242: 710-716.
38. Nowak JZ, (2006) Age-related macular degeneration (AMD): pathogenesis and therapy. Pharmacol Rep 58: 353-363.
39. Miller JW, Adamis AP, Shima DT, D'Amore PA, Moulton RS, (1994) Vascular endothelial growth factor/vascular permeability factor is temporally and spatially correlated with ocular angiogenesis in a primate model. Am J Pathol 145: 574-584.
40. Pe'er J, Folberg R, Itin A, Gnessin H, Hemo I, et al. (1996) Upregulated expression of vascular endothelial growth factor in proliferative diabetic retinopathy. Br J Ophthalmol 80: 241-245.
41. Witmer AN, Vrensen GF, Van Noorden CJ, Schlingemann RO, (2003) Vascular endothelial growth factors and angiogenesis in eye disease. Prog Retin Eye Res 22: 1-29.
42. Blaauwgeers HG, Holtkamp GM, Rutten H, Witmer AN, Koolwijk P, et al. (1999) Polarized vascular endothelial growth factor secretion by human retinal pigment epithelium and localization of vascular endothelial growth factor receptors on the inner choriocapillaris. Evidence for a trophic paracrine relation. Am J Pathol 155: 421-428.
43. Frank RN, Amin RH, Eliott D, Puklin JE, Abrams GW, (1996) Basic fibroblast growth factor and vascular endothelial growth factor are present in epiretinal and choroidal neovascular membranes. Am J Ophthalmol 122: 393-403.
44. Lashkari K, Rahimi N, Kazlauskas A, (1999) Hepatocyte growth factor receptor in human RPE cells: implications in proliferative vitreoretinopathy. Invest Ophthalmol Vis Sci 40: 149-156.
45. Briggs MC, Grierson I, Hiscott P, Hunt JA, (2000) Active scatter factor (HGF/SF) in proliferative vitreoretinal disease. Invest Ophthalmol Vis Sci 41: 3085-3094.
46. Alex AF, Spitznas M, Tittel AP, Kurts C, Eter N, (2010) Inhibitory effect of epigallocatechingallate (EGCG), resveratrol, and curcumin on proliferation of human retinal pigment epithelial cells in vitro. Curr Eye Res 35: 1021-1033.
47. Kaarniranta K, Ryhänen T, Sironen RK, Suuronen T, Elo MA, et al. (2005) Geldanamycin activates Hsp70 response and attenuates okadaic acid-induced cytotoxicity in human retinal pigment epithelial cells. Brain Res Mol Brain Res 137: 126-31.
48. Hollborn M, Bringmann A, Faude F, Wiedemann P, Kohen L, (2006) Signaling pathways involved in PDGF-evoked cellular responses in human RPE cells. Biochem Biophys Res Commun 344: 912-919.
49. Hollborn M, Petto C, Steffen A, Trettner S, Bendig A, et al. (2009) Effects of thrombin on RPE cells are mediated by transactivation of growth factor receptors. Invest Ophthalmol Vis Sci 50: 4452-4459.
50. Fraser-Bell S, Kaines A, Hykin PG, (2008) Update on treatments for diabetic macular edema. Curr Opin Ophthalmol 19: 185-189.
51. Galluzzi L, Blomgren K, Kroemer G, (2009) Mitochondrial membrane permeabilization in neuronal injury. Nat Rev Neurosci 10: 481-494.
52. Crompton M, Ellinger H, Costi A, (1988) Inhibition by cyclosporin A of a Ca2+-dependent pore in heart mitochondria activated by inorganic phosphate and oxidative stress. Biochem J 255: 357-360.
53. Ciocca DR, Calderwood SK, (2005) Heat shock proteins in cancer: diagnostic, prognostic, predictive, and treatment implications. Cell Stress Chaperones 10: 86-103.
54. Kaarniranta K, Salminen A, Eskelinen EL, Kopitz J, (2009) Heat shock proteins as gate keepers of proteolytic pathways-Implications for age-related macular degeneration (AMD). Ageing Res Rev 8: 128-139.
55. Aggarwal BB, Ichikawa H, Garodia P, Weerasinghe P, Sethi G, et al. (2006) From traditional Ayurvedic medicine to modern medicine: identification of therapeutic targets for suppression of inflammation and cancer. Expert Opin Ther Targets10: 87-118.
56. Strimpakos AS, Sharma RA, (2008) Curcumin: preventive and therapeutic properties in laboratory studies and clinical trials. Antioxid Redox Signal 10: 511-545.
57. Puliyappadamba VT, Cheriyan VT, Thulasidasan AK, Bava SV, Vinod BS, et al. (2010) Nicotine-induced survival signaling in lung cancer cells is dependent on their p53 status while its down-regulation by curcumin is independent. Mol Cancer 9: 220.
58. Saha A, Kuzuhara T, Echigo N, Fujii A, Suganuma M, et al. (2010) Apoptosis of human lung cancer cells by curcumin mediated through up-regulation of "growth arrest and DNA damage inducible genes 45 and 153". Biol Pharm Bull 33: 1291-1299.
59. Singh M, Singh N, (2011) Curcumin counteracts the proliferative effect of estradiol and induces apoptosis in cervical cancer cells. Mol Cell Biochem 347: 1-11.
60. Mudduluru G, George-William JN, Muppala S, Asangani IA, Regalla K, et al. (2011) Curcumin regulates miR-21 expression and inhibits invasion and metastasis in colorectal cancer. Biosci Rep 31: 185-197.
61. Peters S, Heiduschka P, Julien S, Ziemssen F, Fietz H, et al. (2007) Ultrastructural findings in the primate eye after intravitreal injection of bevacizumab. Am J Ophthalmol 143: 995-1002.
62. Hashimoto M, Sagara Y, Langford D, Everall IP, Mallory M, et al. (2002) Fibroblast growth factor 1 regulates signaling via the glycogen synthase kinase-3ß pathway. Implications for neuroprotection. J Biol Chem 277: 32985-32991.
63. Franke TF, Hornik CP, Segev L, Shostak GA, Sugimoto C, (2003) PI3K/Akt and apoptosis: size matters. Oncogene 22: 8983-8998.
64. O'Driscoll C, Wallace D, Cotter TG, (2007) bFGF promotes photoreceptor cell survival in vitro by PKA-mediated inactivation of glycogen synthase kinase 3ß and CREB-dependent Bcl-2 up-regulation. J Neurochem 103: 860-870.
65. Halapin NA, Bazan NG, (2010) NPD1 induction of retinal pigment epithelial cell survival involves PI3K/Akt phosphorylation signaling. Neurochem Res 35: 1944-1947.
66. Hung CM, Su YH, Lin HY, Lin JN, Liu LC, et al. (2012) Demethoxycurcumin modulates prostate cancer cell proliferation via AMPK-induced down-regulation of HSP70 and EGFR. J Agric Food Chem 60: 8427-8434.
67. Kishor A, Tandukar B, Ly YV, Toth EA, Suarez Y, et al. (2013) HSP70 is a novel posttranscriptional regulator of gene expression that binds and stabilizes selected mRNAs containing AU-rich elements. Mol Cell Biol 33: 71-84.
68. Liang FQ, Godley BF, (2003) Oxidative stress-induced mitochondrial DNA damage in human retinal pigment epithelial cells: a possible mechanism for RPE aging and age-related macular degeneration. Exp Eye Res 76: 397-403.